Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
Frontiers in Health Services|July 10, 2026
Time course of postmortem procedures in a palliative care unitTamio Okimoto, Shintaro Shimizu, Ken Yoshihara, et al.
Internal Medicine (Tokyo, Japan)|December 17, 2023
Cytokine Release Syndrome More than Two Years after Pembrolizumab IntroductionKazuhisa Nakashima, Kashu Kitani, Kento Kono, et al.
International Journal of General Medicine|June 5, 2023
A Retrospective Study of Pneumococcal Pneumonia in Hospitalized Patients Aged ≥65 Years in Izumo, Japan: 2010 to 2014Megumi Hamaguchi, Yukari Tsubata, Ken Yoshihara, et al.
Modern Rheumatology|June 13, 2009
Classification of clinical subtypes, patient survival, kidney prognosis, and relapse in patients with MPO-ANCA-associated vasculitis: a single-center experienceKimimasa Nakabayashi, Yoshihiro Arimura, Ken Yoshihara, et al.
The Annals of Thoracic Surgery|October 26, 2010
Cardiac swinging calcified amorphous tumors in end-stage renal failure patientsHiroshi Kubota, Yasunori Fujioka, Hideaki Yoshino, et al.
Vaccine|January 31, 2025
A-910823, a squalene-based emulsion adjuvant, enhances robust and broad immune responses of quadrivalent influenza vaccine in ferretsMasayuki Hashimoto, Kenichiro Tsujii, Hitomi Nakajima-Yoshida, et al.
Journal of Medicinal Chemistry|March 17, 2026
Discovery of Highly Selective HDAC2 Inhibitors in Cells That Elevate Histone Acetylation In Vivo without Adverse Effects from Dual Inhibition of HDAC1 and 2Naoyuki Suzuki, Hidekuni Yamakawa, Ken Yoshihara, et al.
The Journal of Medical Investigation : JMI|November 8, 2023
Prognosis of frail older patients treated with intubation and artificial ventilation for respiratory failureKazuhisa Nakashima, Ken Yoshihara, Kento Kono, et al.
Vaccine|June 12, 2022
Immunogenicity and protective efficacy of SARS-CoV-2 recombinant S-protein vaccine S-268019-b in cynomolgus monkeysMasayuki Hashimoto, Noriyo Nagata, Tomoyuki Homma, et al.
Therapeutic Advances in Medical Oncology|February 17, 2025
Clinical impact of hypomagnesemia induced by necitumumab plus cisplatin and gemcitabine treatment in patients with advanced lung squamous cell carcinoma: a subanalysis of the NINJA studyShigeru Tanzawa, Hiroshige Yoshioka, Toshihiro Misumi, et al.
Pageof 3